V2 Financial Group LLC Exact Sciences Corp Transaction History

V2 Financial Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 10, 2024	SELL	$65.94 - $99.04 $148,760 - $223,434	-2,256 Closed	0 $0
Q2 2023 May 10, 2024	BUY	$62.68 - $95.05 $141,406 - $214,432	2,256 New	2,256 $212 Million
Q1 2022 May 10, 2024	SELL	$57.56 - $82.54 $159,786 - $229,131	-2,776 Closed	0 $0
Q4 2021 May 10, 2024	SELL	$72.5 - $100.68 $24,650 - $34,231	-340 Reduced 10.91%	2,776 $216 Million
Q3 2021 May 10, 2024	BUY	$90.24 - $124.05 $281,187 - $386,539	3,116 New	3,116 $297 Million
Q2 2021 May 10, 2024	SELL	$93.66 - $139.27 $3,652 - $5,431	-39 Reduced 1.44%	2,661 $331 Million
Q1 2021 May 10, 2024	BUY	$116.57 - $155.01 $314,739 - $418,527	2,700 New	2,700 $356 Million

670

163M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.36B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of V2 Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on V2 Financial Group LLC with notifications on news.